These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 22460946)
1. A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction. Zuccato C; Breda L; Salvatori F; Breveglieri G; Gardenghi S; Bianchi N; Brognara E; Lampronti I; Borgatti M; Rivella S; Gambari R Ann Hematol; 2012 Aug; 91(8):1201-13. PubMed ID: 22460946 [TBL] [Abstract][Full Text] [Related]
2. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Fibach E; Bianchi N; Borgatti M; Prus E; Gambari R Blood; 2003 Aug; 102(4):1276-81. PubMed ID: 12738678 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer. Wilber A; Hargrove PW; Kim YS; Riberdy JM; Sankaran VG; Papanikolaou E; Georgomanoli M; Anagnou NP; Orkin SH; Nienhuis AW; Persons DA Blood; 2011 Mar; 117(10):2817-26. PubMed ID: 21156846 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients. Breda L; Casu C; Gardenghi S; Bianchi N; Cartegni L; Narla M; Yazdanbakhsh K; Musso M; Manwani D; Little J; Gardner LB; Kleinert DA; Prus E; Fibach E; Grady RW; Giardina PJ; Gambari R; Rivella S PLoS One; 2012; 7(3):e32345. PubMed ID: 22479321 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with Zuccato C; Cosenza LC; Zurlo M; Lampronti I; Borgatti M; Scapoli C; Gambari R; Finotti A Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948226 [TBL] [Abstract][Full Text] [Related]
6. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition. Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524 [TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture. Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564 [TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea responsiveness in β-thalassemic patients is determined by the stress response adaptation of erythroid progenitors and their differentiation propensity. Pourfarzad F; von Lindern M; Azarkeivan A; Hou J; Kia SK; Esteghamat F; van Ijcken W; Philipsen S; Najmabadi H; Grosveld F Haematologica; 2013 May; 98(5):696-704. PubMed ID: 23100274 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells. Mischiati C; Sereni A; Lampronti I; Bianchi N; Borgatti M; Prus E; Fibach E; Gambari R Br J Haematol; 2004 Aug; 126(4):612-21. PubMed ID: 15287957 [TBL] [Abstract][Full Text] [Related]
10. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders. Ali H; Khan F; Musharraf SG Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256 [TBL] [Abstract][Full Text] [Related]
11. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A. Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020 [TBL] [Abstract][Full Text] [Related]
12. The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Persons DA; Hargrove PW; Allay ER; Hanawa H; Nienhuis AW Blood; 2003 Mar; 101(6):2175-83. PubMed ID: 12411297 [TBL] [Abstract][Full Text] [Related]
13. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients. Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480 [TBL] [Abstract][Full Text] [Related]
14. Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells. Bianchi N; Finotti A; Ferracin M; Lampronti I; Zuccato C; Breveglieri G; Brognara E; Fabbri E; Borgatti M; Negrini M; Gambari R PLoS One; 2015; 10(4):e0121567. PubMed ID: 25849663 [TBL] [Abstract][Full Text] [Related]
16. A Novel BaEVRless-Pseudotyped γ-Globin Lentiviral Vector Drives High and Stable Fetal Hemoglobin Expression and Improves Thalassemic Erythropoiesis Drakopoulou E; Georgomanoli M; Lederer CW; Kleanthous M; Costa C; Bernadin O; Cosset FL; Voskaridou E; Verhoeyen E; Papanikolaou E; Anagnou NP Hum Gene Ther; 2019 May; 30(5):601-617. PubMed ID: 30324804 [TBL] [Abstract][Full Text] [Related]
17. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line. Zein S; Li W; Ramakrishnan V; Lou TF; Sivanand S; Mackie A; Pace B Exp Biol Med (Maywood); 2010 Nov; 235(11):1385-94. PubMed ID: 20975082 [TBL] [Abstract][Full Text] [Related]
18. IOX1 Fails to Reduce α-Globin and Mediates γ-Globin Silencing in Adult β Khamphikham P; Wongborisuth C; Pornprasert S; Tantiworawit A; Tangprasittipap A; Songdej D; Hongeng S Exp Hematol; 2022; 112-113():9-14.e7. PubMed ID: 35839944 [TBL] [Abstract][Full Text] [Related]
19. UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells. Nualkaew T; Khamphikham P; Pongpaksupasin P; Kaewsakulthong W; Songdej D; Paiboonsukwong K; Sripichai O; Engel JD; Hongeng S; Fucharoen S; Jearawiriyapaisarn N Ann Hematol; 2020 Sep; 99(9):2027-2036. PubMed ID: 32567028 [TBL] [Abstract][Full Text] [Related]